Brief: RegeneRx Biopharmaceuticals announces $1.75 mln private placement
27/06/2016 13:30
June 27 (Reuters) - RegeneRx Biopharmaceuticals Inc
RGRX.PK
* RegeneRx Biopharmaceuticals Inc says has entered into a
definitive agreement to sell 5.1 million shares of common stock
at a purchase price of $0.34 per share
* RegeneRx announces $1.75 million private placement
Source text for Eikon: ID:nPnrvLhKa
Further company coverage: RGRX.PK
Recent news on RegeneRx Biopharmaceuticals
See all newsBrief: Regenerx Effects Reverse Stock Split, Terminates SEC Reporting Obligations
Brief: Regenerx Receives Stockholder Approval For Reverse Stock Split
Brief: First Patient Enrolled Into U.S. Phase 3 Neurotrophic Keratitis Clinical Trial With Rgn-259
Brief: RegeneRx Publishes RGN-259 Phase 3 Clinical Trial Results
Brief: Regenerx Reports Topline Results Of Arise-3 Dry Eye Trial